Neurothrombectomy Devices

Neurothrombectomy Devices Market by Product (Aspiration/Suction Devices, Clot Retrievers, Vascular Snares), Therapeutic Application (Arteriovenous Malformations (AVMs) & AV Fistulas, Cerebral Aneurysms, Cerebral Artery Stenosis), End-Use - Global Forecast 2024-2030

360iResearch Analyst
Want to know more about the neurothrombectomy devices market or any specific requirement? Ketan helps you find what you're looking for.
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[191 Pages Report] The Neurothrombectomy Devices Market size was estimated at USD 780.01 million in 2023 and expected to reach USD 875.00 million in 2024, at a CAGR 12.66% to reach USD 1,797.13 million by 2030.

Neurothrombectomy Devices Market
To learn more about this report, request a free PDF copy
Neurothrombectomy devices are specialized medical instruments designed to remove clots from the blood vessels within the brain, aiming to rapidly restore blood flow and minimize the damage caused by stroke. These devices are pivotal in the treatment of acute ischemic strokes and have undergone significant innovations to improve efficacy and patient outcomes. The adoption of neurothrombectomy devices is driven by several factors, including the increasing incidence of strokes globally, advancements in medical technology facilitating higher success rates of thrombectomy, and a growing awareness of the importance of timely treatment for stroke patients. In addition, the aging population, which is at a higher risk of stroke, propels the demand for these devices. However, the industry encounters several restraints, such as the high cost of neurothrombectomy procedures and devices, which can limit accessibility for patients in lower-income countries. Additionally, the stringent regulatory requirements for approval and the need for specialized training for healthcare professionals to perform these procedures pose challenges to their adoption. Moreover, there are numerous opportunities, including the integration of AI and machine learning for better decision-making in stroke management and the potential expansion in emerging economies. Continuous research and development activities focused on enhancing device effectiveness and patient safety can propel the industry forward, effectively addressing the global burden of stroke.
Neurothrombectomy Devices Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Neurothrombectomy Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Neurothrombectomy Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Neurothrombectomy Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acandis GmbH, Argon Medical Devices, Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Medtronic Plc, NeuroVasc Technologies, Inc., Penumbra, Inc., Stryker Corporation, Teleflex Incorporated, Terumo Corporation, and Vesalio, LLC.

Market Segmentation & Coverage

This research report categorizes the Neurothrombectomy Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Aspiration/Suction Devices
    • Clot Retrievers
    • Vascular Snares
  • Therapeutic Application
    • Arteriovenous Malformations (AVMs) & AV Fistulas
    • Cerebral Aneurysms
    • Cerebral Artery Stenosis
    • Ischemic Stroke
  • End-Use
    • Ambulatory Surgical Centers
    • Emergency Clinics
    • Hospitals

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Neurothrombectomy Devices Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Neurothrombectomy Devices Market?
  3. What are the technology trends and regulatory frameworks in the Neurothrombectomy Devices Market?
  4. What is the market share of the leading vendors in the Neurothrombectomy Devices Market?
  5. Which modes and strategic moves are suitable for entering the Neurothrombectomy Devices Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Neurothrombectomy Devices Market, by Product
  7. Neurothrombectomy Devices Market, by Therapeutic Application
  8. Neurothrombectomy Devices Market, by End-Use
  9. Americas Neurothrombectomy Devices Market
  10. Asia-Pacific Neurothrombectomy Devices Market
  11. Europe, Middle East & Africa Neurothrombectomy Devices Market
  12. Competitive Landscape
  13. Competitive Portfolio
  14. List of Figures [Total: 22]
  15. List of Tables [Total: 288]
  16. List of Companies Mentioned [Total: 14]
Frequently Asked Questions
  1. How big is the Neurothrombectomy Devices Market?
    Ans. The Global Neurothrombectomy Devices Market size was estimated at USD 780.01 million in 2023 and expected to reach USD 875.00 million in 2024.
  2. What is the Neurothrombectomy Devices Market growth?
    Ans. The Global Neurothrombectomy Devices Market to grow USD 1,797.13 million by 2030, at a CAGR of 12.66%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.